Michael A. Nauck

Ruhr University Bochum

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial”.

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial

Diabetes Care(2020)10.2337/dc19-2251

N/A

5.2DataRank · unranked

174 citations

Stephen C. Bain, Johannes F.E. Mann, Michael A. Nauck, Steven E. Nissen, Stuart Pocock +7 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

New England Journal of Medicine(2016)10.1056/nejmoa1603827

N/A

1.3DataRank · unranked

7197 citations

Gilbert H. Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F.E. Mann, Michael A. Nauck +13 more

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes

UNC Libraries(2020)10.17615/5vsp-zn15

N/A

0DataRank · unranked

15 citations

Peter Lommer Kristensen, Lasse Steen Ravn, Richard M. Bergenstal, Stuart Pocock, Neil R. Poulter +10 more

Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2021)10.1210/clinem/dgab585

N/A

0DataRank · unranked

87 citations

William T. Cefalu, Philip Evans, Hertzel C. Gerstein, Michael A. Nauck, William Oh +7 more

Design of the liraglutide effect and action in diabetes: Evaluation of cardiovascular outcome results (LEADER) trial

UNC Libraries(2021)10.17615/4ena-v672

N/A

0DataRank · unranked

0 citations

Kirstine Brown Frandsen, Johannes F.E. Mann, John B. Buse, Steven E. Nissen, William M. Steinberg +9 more